Leriglitazone
Leriglitazone Uses, Dosage, Side Effects, Food Interaction and all others data.
Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).
| Trade Name | Leriglitazone |
| Generic | Leriglitazone |
| Leriglitazone Other Names | Leriglitazone |
| Type | |
| Formula | C19H20N2O4S |
| Weight | Average: 372.438 Monoisotopic: 372.114377828 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Leriglitazone
